Corey Cutler, MD, MPH
Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Corey Cutler, MD, MPH as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:21 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05922761 · BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)Dana-Farber Cancer Institute · recruiting · Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases · principal investigator
- Ph2NCT02867384 · Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell TransplantationDana-Farber Cancer Institute · completed · Graft vs. Host Disease
- Ph2NCT02176031 · Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHDDana-Farber Cancer Institute · completed · Graft Versus Host Disease · principal investigator
- Ph1NCT00890500 · Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.Fate Therapeutics · completed · Hematologic Malignancies, Allogeneic Stem Cell Transplantation · principal investigator
- Ph1NCT00495755 · Campath in Chronic GVHDDana-Farber Cancer Institute · completed · Chronic Graft-vs.-Host Disease
- Ph2NCT00144703 · Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationDana-Farber Cancer Institute · completed · Hematologic Malignancies, Myelogenous Leukemia, Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT00144677 · Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationDana-Farber Cancer Institute · completed · Acute Myelogenous Leukemia, Graft Versus Host Disease, Acute Lymphoblastic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.